APPLICATION
ANDA078399
TYPE
ANDA
ORIGINAL APPROVAL
2009-11-05
LATEST ACTION
2023-03-27
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued
Products
KETOROLAC TROMETHAMINEDiscontinued
KETOROLAC TROMETHAMINE 0.4% · SOLUTION/DROPS · OPHTHALMIC
Approval history
2023-03-27Labeling · Supplement 5 · standardAP
2016-11-14Labeling · Supplement 3 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.